Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

INTRODUCTION. We assessed the incidence and timing of first cardiac events, impact on trastuzumab prescription, and role of left ventricular ejection fraction (LVEF) monitoring in daily practice of trastuzumab-treated patients with human epidermal growth receptor 2 (HER2)-positive early breast cance...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Seferina, Shanly C., de Boer, Maaike, Derksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Joore, Manuela, Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2016
Teme:
Breast Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861356/
https://ncbi.nlm.nih.gov/pubmed/27009939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0230
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki